Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
Work
Year: 2021
Type: article
Abstract: Following severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine1,2, European health authorities recommended that patients under the age of 55 years who received one dose of ChAdOx1-S-n... more
Source: Nature
Authors Bruno Pozzetto, Vincent Legros, Sophia Djebali, Véronique Barateau, Nicolas Guibert +32 more
Institutions Université Jean Monnet, École Normale Supérieure de Lyon, Inserm, Université Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie +6 more
Cites: 31
Cited by: 198
Related to: 10
FWCI: 12.85
Citation percentile (by year/subfield): 100
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $2,329